Request Demo
Last update 24 May 2025
V-938
Last update 24 May 2025
Overview
Basic Info
Drug Type Biological products |
Synonyms V 938, V938 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with V-938NCT04135352
A Phase 1/1b, Open-label Clinical Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies
100 Clinical Results associated with V-938
Login to view more data
100 Translational Medicine associated with V-938
Login to view more data
100 Patents (Medical) associated with V-938
Login to view more data
100 Deals associated with V-938
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | United States | 04 Nov 2019 | |
| Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | Canada | 04 Nov 2019 | |
| Advanced Head and Neck Squamous Cell Carcinoma | Phase 1 | Israel | 04 Nov 2019 | |
| Melanoma | Phase 1 | United States | 04 Nov 2019 | |
| Melanoma | Phase 1 | Canada | 04 Nov 2019 | |
| Melanoma | Phase 1 | Israel | 04 Nov 2019 | |
| Metastatic melanoma | Phase 1 | United States | 04 Nov 2019 | |
| Metastatic melanoma | Phase 1 | Canada | 04 Nov 2019 | |
| Metastatic melanoma | Phase 1 | Israel | 04 Nov 2019 | |
| Metastatic Solid Tumor | Phase 1 | United States | 04 Nov 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 35 | (Dose Expansion Arm A, Melanoma) | bgxfeluatf = pobvatorxt ngmxvodseh (kzwxsgdkte, fwquutxziq - dlqgqsoscg) View more | - | 12 Nov 2024 | ||
(Dose Expansion Arm B, HNSCC) | bgxfeluatf = suncmsimzm ngmxvodseh (kzwxsgdkte, gfrwwynznu - pwyylyfkpv) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free